Evidence map›Paper›PMID 40289646›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Survey on diagnosis and treatment of cognitive impairment in Sichuan area in China.

Rui Gu, Hua Liu, Xiaoling Zhao, Xiaohai He, Qingyan Cai, Liang Gong, Xiaoling Song, Yao Xiong, Yan Huang, Linling Xu and 9 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Survey on diagnosis and treatment of cognitive impairment in Sichuan area in China.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Rui GuDepartment of Neurology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Hua LiuDepartment of Neurology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Xiaoling ZhaoDepartment of Neurology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Xiaohai HeCollege of Electronics and Information Engineering, Sichuan University, Chengdu, Sichuan, China.
Qingyan CaiDepartment of Geriatric Psychiatry, The Fourth People's Hospital of Chengdu, Chengdu, Sichuan, China.
Liang GongDepartment of Neurology, Chengdu Second People's Hospital, The Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
Xiaoling SongDepartment of Neurology, ChengFei Hospital, Chengdu, Sichuan Province, China.
Yao XiongDepartment of Neurology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Yan HuangDepartment of Neurology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Linling XuDepartment of Neurology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Kemeng WangDepartment of Neurology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Na CaoDepartment of Neurology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Mi XiongDepartment of Neurology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Xi ZhuDepartment of Neurology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Qing YeDepartment of Neurology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Zheng ZhangDepartment of Neurology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Ming XianDepartment of Neurology, Yingjing County People's Hospital, Ya'an, Sichuan Province, China.
Hu ZhangInternet Hospital Management Department, The Third People's Hospital of Chengdu, Chengdu, Sichuan Province, China.
Yan LiuDepartment of Neurology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.

Funding

Chengdu Medical Research Project 2022161Chengdu Science and Technology 2019-YF09-00120-SNChengdu Science and Technology Department project 2024-YF05-00958-SNMedical Research Project of Chengdu Municipal Health Commission 2022179Sichuan Provincial Science and Technology Department project in China 2024ZYD0136The Science and Technology Department of Sichuan Province 2023YFS0115
6 · The paper itself

Abstract

introductionDementia imposes significant economic and emotional burdens, with cognitive impairment in China expected to rise. However, diagnosis and treatment remain inadequately standardized. This study surveyed cognitive impairment diagnosis and treatment in Sichuan, China.

methodsA retrospective multicenter study analyzed inpatient records from 13 medical institutions over the past 5 years.

resultsPatients exhibited delayed medical care-seeking, primarily visiting tertiary hospitals, where diagnostic and treatment capabilities were superior. Alzheimer's disease (AD) was the most common diagnosis, with memory impairment as the predominant initial symptom. Both pharmacological and non-pharmacological treatments were insufficient. DISCUSSION: Findings underscore the need to enhance health education, allocate more diagnostic and intervention resources, and strengthen primary healthcare to improve care quality for patients with cognitive impairment in Sichuan. HIGHLIGHTS: The prevalence of cognitive impairment in China is expected to surge significantly. Despite this trend, the diagnosis and treatment of cognitive disease in China remain unstandardized. A multicenter retrospective study of inpatient records with cognitive impairment or dementia as the first diagnosis treated at 13 medical facilities across Sichuan Province over the past 5 years was performed. The analysis revealed a pattern of delayed medical care-seeking among patients who predominantly accessed tertiary hospitals. Alzheimer's disease (AD) emerged as the most common diagnosis. Memory impairment was identified as the most frequent initial symptom. Tertiary hospitals demonstrated superior diagnostic and treatment capabilities compared to non-tertiary institutions. In addition, the results revealed that the patients received fewer pharmacological and non-pharmacological treatments. The findings highlight the urgent need for the Sichuan region to strengthen health education on cognitive impairment, allocate more diagnostic and intervention resources, and enhance primary healthcare capabilities to improve the quality of care and life for patients with cognitive impairment.

Indexed as

Cognitive DysfunctionAgedAged, 80 and overAlzheimer DiseaseChinaFemaleHumansMaleMiddle AgedPatient Acceptance of Health CareRetrospective StudiesSurveys and QuestionnairesChinacognitive impairment diseasedementiadiagnosisSichuantreatment

Identifiers

PMID40289646
PMCPMC12034935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.